Anew Medical, Inc. (WENA)
USD 0.73
(-3.84%)
USD 0.73
(-3.84%)
| Breakdown | 2023 | 2022 | 2021 |
|---|---|---|---|
| Revenue | - | - | - |
| Cost of Revenue | - | - | - |
| Gross Profit | - | - | - |
| Operating Expenses | 1.3 Million | 657.02 Thousand | 1.1 Million |
| Selling, General and Administrative Expenses | 1.22 Million | 533.99 Thousand | 1.1 Million |
| Research and Development Expenses | - | - | - |
| Other Expenses | -75.6 Thousand | -123.03 Thousand | 44.00 |
| Cost and Expenses | 1.3 Million | 657.01 Thousand | 1.1 Million |
| Operating Income | -1.3 Million | -657.02 Thousand | -1.1 Million |
| Interest Expense | - | 24.36 Thousand | - |
| Income Tax Expense | 690.57 Thousand | 322.02 Thousand | - |
| Earnings before Tax | 2.03 Million | 1.55 Million | -1.1 Million |
| Net Income | 1.34 Million | 1.23 Million | -1.1 Million |
| Earnings Per Share Basic | 0.14 | 0.08 | -0.09 |
| Earnings Per Share Diluted | 0.14 | 0.08 | -0.09 |
| Weighted Average Shares Outstanding | 9.75 Million | 14.9 Million | 12.97 Million |
| Weighted Average Shares Outstanding (Diluted) | 9.75 Million | 14.9 Million | 12.97 Million |
| Gross Margin | - | - | - |
| EBIT Margin | - | - | - |
| Profit Margin | - | - | - |
| EBITDA | -1.3 Million | -574.22 Thousand | -1.1 Million |
| Earnings Before Tax Margin | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
| Operating Expenses | 395.6 Thousand | 342.77 Thousand | 324.9 Thousand | 1.3 Million | 292.22 Thousand | 357.95 Thousand |
| Selling, General and Administrative Expenses | 395.6 Thousand | 324.77 Thousand | 348.3 Thousand | - | 259.22 Thousand | 324.05 Thousand |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | -18 Thousand | 23.4 Thousand | -75.6 Thousand | -33 Thousand | -33.9 Thousand |
| Cost and Expenses | 395.6 Thousand | 342.77 Thousand | 324.9 Thousand | 1.3 Million | 292.22 Thousand | 357.95 Thousand |
| Operating Income | -395.61 Thousand | -342.78 Thousand | -324.91 Thousand | -1.3 Million | -292.23 Thousand | -357.95 Thousand |
| Interest Expense | 15.06 Thousand | - | - | - | - | 20.15 Thousand |
| Income Tax Expense | - | 49.06 Thousand | 111.99 Thousand | 690.57 Thousand | 148.85 Thousand | 173.94 Thousand |
| Earnings before Tax | -451.63 Thousand | -74.15 Thousand | 200.91 Thousand | 2.03 Million | 439 Thousand | 20.4 Thousand |
| Net Income | -451.63 Thousand | -123.22 Thousand | 88.91 Thousand | 1.34 Million | 290.14 Thousand | -153.54 Thousand |
| Earnings Per Share Basic | -0.03 | -0.02 | 0.02 | - | 0.03 | -0.02 |
| Earnings Per Share Diluted | -0.03 | -0.02 | 0.02 | - | 0.03 | -0.02 |
| Weighted Average Shares Outstanding | 15.05 Million | 5.16 Million | 5.16 Million | 9.75 Million | 8.8 Million | 8.8 Million |
| Weighted Average Shares Outstanding (Diluted) | 15.05 Million | 5.16 Million | 5.16 Million | 9.75 Million | 8.8 Million | 8.8 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -395.61 Thousand | -342.78 Thousand | -324.91 Thousand | - | -292.23 Thousand | -357.95 Thousand |
| Earnings Before Tax Margin | - | - | - | - | - | - |
SRES
300047
SVRA
MFT
MAZDOCK
DGV